Induction of autoantibodies against lung matrix proteins and smoke-induced inflammation in mice

BMC Pulmonary Medicine

Volumn 10, Issue , 2010, Pages

  Brandsma, Corry Anke ^a   Timens, Wim ^a   Geerlings, Marie ^a   Jekel, Henrike ^a   Postma, Dirkje S ^a   Hylkema, Machteld N ^a   Kerstjens, Huib A M ^a  

^a UNIVERSITY MEDICAL CENTER GRONINGEN   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

AUTOANTIBODY; CIGARETTE SMOKE; COLLAGEN; CYTOKINE; DECORIN; ELASTIN; GAMMA INTERFERON; GAMMA INTERFERON INDUCIBLE PROTEIN 10; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; INTERLEUKIN 10; INTERLEUKIN 12; INTERLEUKIN 17; INTERLEUKIN 1ALPHA; INTERLEUKIN 1BETA; INTERLEUKIN 2; INTERLEUKIN 4; INTERLEUKIN 5; INTERLEUKIN 6; MONOCYTE CHEMOTACTIC PROTEIN 1; TUMOR NECROSIS FACTOR ALPHA; VASCULOTROPIN; SCLEROPROTEIN;

ANIMAL CELL; ANIMAL TISSUE; ANTIBODY BLOOD LEVEL; ANTIBODY PRODUCING CELL; ARTICLE; B LYMPHOCYTE; CELL COUNT; CHRONIC OBSTRUCTIVE LUNG DISEASE; CONTROLLED STUDY; DISEASE COURSE; EMPHYSEMA; EXPOSURE; EXTRACELLULAR MATRIX; FEMALE; HUMORAL IMMUNITY; IMMUNE RESPONSE; IMMUNIZATION; INFLAMMATION; INFLAMMATORY CELL; LUNG; LUNG HOMOGENATE; LUNG PARENCHYMA; MACROPHAGE; MOUSE; NEUTROPHIL; NONHUMAN; SMOKE; SPLEEN; ANIMAL; BLOOD; C57BL MOUSE; DISEASE MODEL; IMMUNOLOGY; LUNG EMPHYSEMA; METABOLISM; PATHOLOGY; PNEUMONIA; SMOKING;

ANIMALS; AUTOANTIBODIES; COLLAGEN; CYTOKINES; DECORIN; DISEASE MODELS, ANIMAL; ELASTIN; EXTRACELLULAR MATRIX PROTEINS; FEMALE; IMMUNIZATION; LUNG; MICE; MICE, INBRED C57BL; PNEUMONIA; PULMONARY EMPHYSEMA; SMOKING;

EID: 78649956146     PISSN: None     EISSN: 14712466     Source Type: Journal    
DOI: 10.1186/1471-2466-10-64     Document Type: Article

References (19)

1. Global Strategy for the Diagnosis, Management and Prevention of COPD, Global Initiative for Chronic Obstructive Lung Disease (GOLD). 2009, http://www.goldcopd.org
2. Sullivan AK, Simonian PL, Falta MT, Mitchell JD, Cosgrove GP, Brown KK, et al. Oligoclonal CD4+ T cells in the lungs of patients with severe emphysema. Am J Respir Crit Care Med 2005, 172:590-596. 10.1164/rccm.200410-1332OC, 2718531, 15937291.
3. Lee SH, Goswami S, Grudo A, Song LZ, Bandi V, Goodnight-White S, et al. Antielastin autoimmunity in tobacco smoking-induced emphysema. Nat Med 2007, 13:567-569. 10.1038/nm1583, 17450149.
4. van der Strate BW, Postma DS, Brandsma CA, Melgert BN, Luinge MA, Geerlings M, et al. Cigarette smoke-induced emphysema: a role for the B cell?. Am J Respir Crit Care Med 2006, 173:751-758. 10.1164/rccm.200504-594OC, 16399994.
5. Hogg JC, Chu F, Utokaparch S, Woods R, Elliott WM, Buzatu L, et al. The nature of small-airway obstruction in chronic obstructive pulmonary disease. N Engl J Med 2004, 350:2645-2653. 10.1056/NEJMoa032158, 15215480.
6. Brusselle GG, Demoor T, Bracke KR, Brandsma CA, Timens W. Lymphoid follicles in (very) severe COPD: beneficial or harmful?. Eur Respir J 2009, 34:219-230. 10.1183/09031936.00150208, 19567605.
7. Brandsma CA, Hylkema MN, Geerlings M, van Geffen WH, Postma DS, Timens W, et al. Increased levels of (class switched) memory B cells in peripheral blood of current smokers. Respir Res 2009, 10:108. 10.1186/1465-9921-10-108, 2779187, 19909533.
8. Feghali-Bostwick CA, Gadgil AS, Otterbein LE, Pilewski JM, Stoner MW, Csizmadia E, et al. Autoantibodies in patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med 2008, 177:156-163. 10.1164/rccm.200701-014OC, 2204079, 17975205.
9. Bonarius HP, Brandsma CA, Kerstjens HA, Koerts JA, Kerkhof M, Nizankowska-Mogilnicka E, et al. Antinuclear autoantibodies are more prevalent in COPD in association with low body mass index but not with smoking history. Thorax 2010,
10. Karayama M, Inui N, Suda T, Nakamura Y, Nakamura H, Chida K. Antiendothelial Cell Antibodies in Patients With COPD. Chest 2010, 138:1303-1308. 10.1378/chest.10-0863, 20576735.
11. Leidinger P, Keller A, Heisel S, Ludwig N, Rheinheimer S, Klein V, et al. Novel autoantigens immunogenic in COPD patients. Respir Res 2009, 10:20. 10.1186/1465-9921-10-20, 2667165, 19284601.
12. Kuo YB, Chang CA, Wu YK, Hsieh MJ, Tsai CH, Chen KT, et al. Identification and clinical association of anti-cytokeratin 18 autoantibody in COPD. Immunol Lett 2010, 128:131-136. 10.1016/j.imlet.2009.12.017, 20038439.
13. Taraseviciene-Stewart L, Scerbavicius R, Choe KH, Moore M, Sullivan A, Nicolls MR, et al. An animal model of autoimmune emphysema. Am J Respir Crit Care Med 2005, 171:734-742. 10.1164/rccm.200409-1275OC, 15563631.
14. Brandsma CA, Hylkema MN, van der Strate BW, Slebos DJ, Luinge MA, Geerlings M, et al. Heme oxygenase-1 prevents smoke induced B-cell infiltrates: a role for regulatory T cells?. Respir Res 2008, 9:17. 10.1186/1465-9921-9-17, 2254411, 18252008.
15. Hylkema MN, Hoekstra MO, Luinge M, Timens W. The strength of the OVA-induced airway inflammation in rats is strain dependent. Clin Exp Immunol 2002, 129:390-396. 10.1046/j.1365-2249.2002.01938.x, 1906482, 12197878.
16. Brandsma CA, Hylkema MN, Luinge MA, Geerlings M, Klok PA, Cassee FR, et al. Nitrogen dioxide exposure attenuates cigarette smoke-induced cytokine production in mice. Inhal Toxicol 2008, 20:183-189. 10.1080/08958370701821342, 18236232.
17. van Straaten JF, Coers W, Noordhoek JA, Huitema S, Flipsen JT, Kauffman HF, et al. Proteoglycan changes in the extracellular matrix of lung tissue from patients with pulmonary emphysema. Mod Pathol 1999, 12:697-705.
18. Goswami S, Barranco W, Lee SH, Grudo A, Corry DB, Kheradmand F. An autoimmune basis in the disease pathogenesis of COPD/emphysema. The Journal of Immunology 178 2007, Abstract.
19. Noordhoek JA, Postma DS, Chong LL, Menkema L, Kauffman HF, Timens W, et al. Different modulation of decorin production by lung fibroblasts from patients with mild and severe emphysema. COPD 2005, 2:17-25. 10.1081/COPD-200050678, 17136957.